Current Clinical Pathology

Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma

Editors: Murphy, Michael J. (Ed.)

  • Reviews major advances in molecular methods, using an evidence-based perspective
  • Explores powerful tools for determining treatment decisions
  • An essential resource for oncologists, dermatologists, pathologists, and melanoma researchers
see more benefits

Buy this book

eBook $199.00
price for USA (gross)
  • ISBN 978-1-60761-433-3
  • Digitally watermarked, DRM-free
  • Included format: PDF, EPUB
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $259.00
price for USA
  • ISBN 978-1-60761-432-6
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Rent the ebook  
  • Rental duration: 1 or 6 month
  • low-cost access
  • online reader with highlighting and note-making option
  • can be used across all devices
About this book

This book describes both the technologies used in the discovery of melanoma biomarkers and the clinical application of these biomarkers for diagnosis and staging of disease, determination of prognosis, treatment planning, monitoring of response to therapy, identification of novel therapeutic targets and drug development. A broad range of biomarkers (DNA/chromosomal, mRNA, microRNA, mitochondrial DNA, epigenetic and protein) is outlined. As therapies for melanoma become increasingly more target specific, the identification, validation and use of biomarkers will invariably play a greater role in the management of patients with this disease. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma is an essential resource for oncologists, dermatologists, dermatopathologists, general pathologists with an interest in melanoma, and melanoma researchers.

Reviews

From the reviews:

“This is a comprehensive overview of biomarkers as they relate to pathogenesis and clinical utility in the diagnosis, staging, and treatment of melanoma. … The audience is practitioners specializing in melanoma, including dermatologists, surgeons, and oncologists, as well as researchers in the field. … book broadly explores the role of molecular diagnostic techniques and specific biomarkers which may serve to facilitate more accurate diagnoses and identify early-stage melanoma patients with high risk for metastasis. … I highly recommend this book for melanoma clinicians and researchers.” (Susan M. Swetter, Doody’s Book Reviews, July, 2012)

Table of contents (23 chapters)

  • Introduction to Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma

    Murphy, Michael J.

    Pages 1-7

  • Diagnostic and Prognostic Biomarkers in Melanoma: Current State of Play

    Utikal, Jochen (et al.)

    Pages 9-18

  • Molecular Pathogenesis of Melanoma: Established and Novel Pathways

    Ascierto, Paolo Antonio (et al.)

    Pages 19-37

  • Staging of Melanoma

    Elaba, Zendee (et al.)

    Pages 39-48

  • Clinical and Histopathological Parameters in Melanoma

    Bilinski, Cheryl (et al.)

    Pages 49-67

Buy this book

eBook $199.00
price for USA (gross)
  • ISBN 978-1-60761-433-3
  • Digitally watermarked, DRM-free
  • Included format: PDF, EPUB
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $259.00
price for USA
  • ISBN 978-1-60761-432-6
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Rent the ebook  
  • Rental duration: 1 or 6 month
  • low-cost access
  • online reader with highlighting and note-making option
  • can be used across all devices
Loading...

Recommended for you

Loading...

Bibliographic Information

Bibliographic Information
Book Title
Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma
Editors
  • Michael J. Murphy
Series Title
Current Clinical Pathology
Copyright
2012
Publisher
Humana Press
Copyright Holder
Springer Science+Business Media, LLC
eBook ISBN
978-1-60761-433-3
DOI
10.1007/978-1-60761-433-3
Hardcover ISBN
978-1-60761-432-6
Series ISSN
2197-781X
Edition Number
1
Number of Pages
XIV, 322
Topics